Policy and Legislation
Rule misleads patients about their out-of-pocket costs for prescription drugs, a factor the manufacturers say HHS already concedes.
Hospitals said cuts to 340B savings would force them to scale back certain programs, though the 340B program remains controversial.
While most vertical mergers do not impair competition, it should not be assumed that all are benign or that savings are passed onto consumers, Senate Judiciary subcommittee hears.
The industry has miles to go before public policies align with social determinants of health, but the increasing pace of change is encouraging, says health economist Jane Sarasohn-Kahn.
Sharp Index founder Janae Sharp says she is watching to see whether the industry will be subject to more regulation and how current payment and incentive models will evolve.
American Hospital Association applauds the decision, in which billions of dollars are at stake.
HIMSS Senior Director of Federal and State Affairs Jeff Coughlin talks sheds insight on information-blocking, interoperability, social determinants and recently proposed rules from CMS and ONC.
Also, HHS revises LGBT discrimination protections in Affordable Care Act it says likely unenforceable and will save $3.6 billion over 5 years.
An additional 355,184 people would have been screened for colorectal cancer if non-expansion states had seen the same increases in screenings.
Measuring digital maturity using tools such as EMRAM enables the NHS to track progress of the global digital exemplars against international standards, says Will Smart, CIO for Health and Social Care in England.